Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Net Debt / EBITDA

Iovance Biotherapeutics Inc Net Debt / EBITDA Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Iovance Biotherapeutics Inc Net Debt / EBITDA for the quarter ending June 06, 2020 was $3m a 42.04% increase of 1m year over year
  • Iovance Biotherapeutics Inc Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $3m a 34.75% increase of 1m year over year
  • Iovance Biotherapeutics Inc Annual Net Debt / EBITDA for 2019 was $2m a -137.35% decrease of -2m from 2018
  • Iovance Biotherapeutics Inc Annual Net Debt / EBITDA for 2018 was $4m a 57.03% increase of 2m from 2017
  • Iovance Biotherapeutics Inc Annual Net Debt / EBITDA for 2017 was $2m a -143.89% decrease of -2m from 2016
Other Ratios Metrics:
  • Iovance Biotherapeutics Inc Total Debt / Capital for the quarter ending March 03, 2010 was $3m
  • Iovance Biotherapeutics Inc Other Liabilities for the quarter ending March 03, 2014 was $0m
  • Iovance Biotherapeutics Inc Total Debt / Equity for the quarter ending March 03, 2010 was $4m
View Chart On Koyfin

Quarterly IOVA Net Debt / EBITDA Data

06/2020$3m
03/2020$1m
12/2019$1m
09/2019$2m
06/2019$2m
03/2019$3m
12/2018$3m
09/2018$2m
06/2018$2m
03/2018$3m

Annual IOVA Net Debt / EBITDA Data

2019$2m
2018$4m
2017$2m
2016$4m
2015$4m
2014$4m
2013$3m
2012$-1m
2011$0m
2010$2m